Delivery Order SPE2DB22D3009-SPE2DB25FBF31
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,124.29 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) under a firm fixed-price contract type. This delivery order, which became effective on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a competitive award with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $29,812.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 29, 2025, with completion expected by September 30, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $5,520.01 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count supply) on September 16, 2025, with completion expected by September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $24,490.92 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (quantity: 8 units). This firm fixed price, competitively awarded delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a $18,204.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-set-aside contract was competitively awarded and represents a routine pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) valued at $35,575.93 under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $24,916.23 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $44,614.84. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $18,492.01 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (quantity 8). This contract, with an ultimate completion date of September 4, 2025, represents a competitive award with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and operates as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a $24,679.00 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) under a firm fixed price arrangement. This non-competitive, non-set-aside delivery order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. NURTEC ODT is a prescription medication used...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBF31Delivery Order
The Defense Logistics Agency awarded a $25,574.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8 count). This non-competed delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item fulfillment under the company's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle designated SPE2DX and running through December 2026. This comprehensive global pharmaceutical support agreement enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. NURTEC ODT is a migraine treatment medication, reflecting the pharmaceutical company's role as a critical vendor for federal medical procurement across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.6k | 9/18/25 |